Who has invested in Emulate?

No investors are named on the public record for Emulate yet.

Emulate Funding: $225M Raised, Series E (2021)

Emulate funding overview

Emulate is a Biotech company based in Boston, Massachusetts. Emulate has raised $225M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series E announced in September 2021. The round record for Emulate runs through 2021; nothing later has been disclosed.

Emulate at a glance

Total raised: $225M
Latest round: Series E
Latest round date: September 2021
Industry: Biotech
Headquarters: Boston, Massachusetts

Frequently asked about Emulate funding

How much has Emulate raised?: Emulate has raised $225M in total disclosed funding across the rounds on record.
Who has invested in Emulate?: No investors are named on the public record for Emulate yet.
What was the latest Emulate funding round?: The most recent disclosed round is a Series E, announced in September 2021.
Where is Emulate based?: Emulate is based in Boston, Massachusetts.
What sector does Emulate operate in?: Emulate is tracked under Biotech from Boston, Massachusetts, with $225M in disclosed funding.
When did Emulate last raise?: The last disclosed Emulate round closed in September 2021 at Series E.

We update the Emulate record whenever a new round is filed or announced, so the totals above track the public record rather than estimates. Related Biotech companies in Boston and their backers are listed below.

Emulate Funding: $225M Raised, Series E (2021)

Emulate funding overview

Emulate at a glance

Frequently asked about Emulate funding

Emulate founders (2)

Companies related to Emulate (33)

Browse related funding lists (5)